{"id":27921,"date":"2026-11-03T09:17:44","date_gmt":"2026-11-03T08:17:44","guid":{"rendered":"https:\/\/ddz.de\/?p=27921"},"modified":"2026-11-03T10:46:25","modified_gmt":"2026-11-03T09:46:25","slug":"new-training-program-at-the-ddz-endodiatrack-supports-clinician-scientists","status":"publish","type":"post","link":"https:\/\/ddz.de\/en\/new-training-program-at-the-ddz-endodiatrack-supports-clinician-scientists\/","title":{"rendered":"New Training Program at the DDZ: ENDODIATRACK Supports Clinician Scientists"},"content":{"rendered":"\n

With ENDODIATRACK (ENDOcrinology and DIAbetology for Translational Research and Advanced Clinical Knowledge), the German Diabetes Center (DDZ) is launching a new program for physicians who wish to bridge the gap between clinical excellence and cutting-edge scientific research. It combines structured clinical training in diabetology and endocrinology with protected research time.<\/strong><\/p>\n\n\n\n

Physicians who also conduct research play a crucial role: They translate the latest research findings into everyday clinical practice and incorporate questions arising from clinical care into research projects.<\/p>\n\n\n\n

Diabetology and endocrinology are constantly evolving: New findings on diabetes subtypes, individual courses of disease, and modern treatment approaches are paving the way for increasingly personalized care. Physicians who also conduct research (clinician scientists) play a crucial role in addressing this complexity: They translate the latest research findings into everyday clinical practice and, conversely, incorporate questions arising from clinical care into research projects.<\/p>\n\n\n\n

With ENDODIATRACK, the DDZ in D\u00fcsseldorf is establishing a unique training opportunity that brings together clinical diabetology, endocrinology, and metabolic medicine. \u201cThe program helps train the next generation of clinician scientists in diabetology, endocrinology, and internal medicine and sustainably strengthen the bridge between research and the care of people with diabetes. In doing so, it contributes to the continued advancement of evidence-based, forward-looking medicine,\u201d says Professor Michael Roden, Scientific Director and Spokesperson of the Board of the DDZ as well as Director of the Department of Endocrinology and Diabetology at the University Hospital D\u00fcsseldorf (UKD).\u00a0<\/p>\n\n\n\n

<\/div>\n\n\n\n
\"\"<\/figure>\n\n\n\n
<\/div>\n\n\n\n

Participants develop an independent scientific profile in the fields of diabetology, endocrinology, and internal medicine. A structured curriculum, individualized mentoring programs, and active participation in clinical and research projects lay the foundation for a long-term career as a clinical academic. In addition to conducting and coordinating clinical trials at the DDZ, particular emphasis is placed on understanding hormonal and metabolic disorders and their interactions throughout the course of disease. <\/p>\n\n\n\n

ENDODIATRACK at a Glance<\/h3>\n\n\n\n